Venlafaxine

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5373 publications

Stopping antidepressants: when and how.

Stopping antidepressants: when and how.

Journal: Australian prescriber

Published: June 18, 2026

Treatment of posttraumatic stress disorder (PTSD).

Treatment of posttraumatic stress disorder (PTSD).

Journal: Dialogues in clinical neuroscience

Published: June 12, 2026

The relation between observer-rated depressive symptoms and patient-rated quality of life after six weeks of antidepressant treatment: pooled patient-level analysis of mirtazapine trials.

The relation between observer-rated depressive symptoms and patient-rated quality of life after six weeks of antidepressant treatment: pooled patient-level analysis of mirtazapine trials.

Journal: BJPsych open

Published: June 09, 2026

Formulation and optimization of venlafaxine loaded nanostructure lipid carrier based intranasal drug delivery system for brain targeting through in vivo study.

Formulation and optimization of venlafaxine loaded nanostructure lipid carrier based intranasal drug delivery system for brain targeting through in vivo study.

Journal: Drug development and industrial pharmacy

Published: May 28, 2026

Association Between Venlafaxine Exposure And Treatment Outcomes In Older Adults With Depression: Association entre l'exposition à la venlafaxine et les résultats du traitement chez les personnes âgées atteintes de dépression.

Association Between Venlafaxine Exposure And Treatment Outcomes In Older Adults With Depression: Association entre l'exposition à la venlafaxine et les résultats du traitement chez les personnes âgées atteintes de dépression.

Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie

Published: May 14, 2026

Pharmacogenetics of venlafaxine response in older adults with depression and chronic lower back pain.

Pharmacogenetics of venlafaxine response in older adults with depression and chronic lower back pain.

Journal: Pharmacogenomics

Published: May 08, 2026

Glaucoma Risk Associated With Calcitonin Gene-Related Peptide Inhibitor Use in Migraine: A Multinational Cohort Study.

Glaucoma Risk Associated With Calcitonin Gene-Related Peptide Inhibitor Use in Migraine: A Multinational Cohort Study.

Journal: Neurology

Published: May 06, 2026

Functional Pharmacobezoar and Bowel Ischemia Requiring Hemicolectomy Complicating Extended-Release Carbamazepine-Venlafaxine Overdose.

Functional Pharmacobezoar and Bowel Ischemia Requiring Hemicolectomy Complicating Extended-Release Carbamazepine-Venlafaxine Overdose.

Journal: Critical care explorations

Published: April 21, 2026

Development of venlafaxine hydrochloride nasal thermosensitive in-situ gel with P407/P188: enhanced bioavailability and antidepressant effects in depressive rats.

Development of venlafaxine hydrochloride nasal thermosensitive in-situ gel with P407/P188: enhanced bioavailability and antidepressant effects in depressive rats.

Journal: Journal of drug targeting

Published: April 20, 2026

Chronic venlafaxine ingestion inducing bluish oral hyperpigmentation with dysgeusia and dysphagia: A case report.

Chronic venlafaxine ingestion inducing bluish oral hyperpigmentation with dysgeusia and dysphagia: A case report.

Journal: The International journal of risk & safety in medicine

Published: April 11, 2026

Recommendations from the Clinical Toxicology Recommendations Collaborative on the administration of activated charcoal in acute oral overdose.

Recommendations from the Clinical Toxicology Recommendations Collaborative on the administration of activated charcoal in acute oral overdose.

Journal: Clinical toxicology (Philadelphia, Pa.)

Published: March 30, 2026

Hyperacusis-inducing drug candidates.

Hyperacusis-inducing drug candidates.

Journal: Hearing research

Published: March 25, 2026

Showing 1-12 of 5,373

Last Updated: 06/30/2026